Free tool
Stocks listed on Stockholm
We cover 44 companies listed on Stockholm. The median market value in the group is $564.79M. Across the group, the median move over the past trading day is +0.77%. 61% of the 44 with a 200-day average trade above it. Price change over the past year runs from −54.6% to +47.5% across the middle 80 percent of the group, with a median of −15.3%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
44 of 928 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% | Oct 30, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% | Nov 4, 2026 |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% | Nov 5, 2026 |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% | Nov 4, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% | Nov 6, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| NOLA-B.ST | Nolato AB (publ) | 51.80 SEK | +6.91% | −10.27% | −7.00% | Oct 29, 2026 |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% | Nov 4, 2026 |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% | Oct 22, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| SYNSAM.ST | Synsam AB (publ) | 59.50 SEK | +5.50% | −7.98% | +5.66% | Nov 12, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% | Oct 23, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% | Oct 21, 2026 |
| APOTEA.ST | Apotea AB (publ) | 75.30 SEK | +1.41% | −16.05% | −26.38% | Nov 5, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% | Oct 22, 2026 |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% | Nov 3, 2026 |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% | Nov 5, 2026 |
| CEVI.ST | CellaVision AB (publ) | 164.00 SEK | +7.47% | +10.88% | −5.28% | Oct 28, 2026 |
| EGTX.ST | Egetis Therapeutics AB (publ) | 7.87 SEK | +25.72% | +52.22% | +51.35% | Nov 6, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| VICO.ST | Vicore Pharma Holding AB (publ) | 10.74 SEK | −0.74% | −2.19% | −1.29% | Nov 5, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | 50.85 SEK | +49.82% | +63.82% | −48.69% | Nov 12, 2026 |
| BICO.ST | BICO Group AB (publ) | 19.92 SEK | +36.25% | −1.19% | −17.00% | Nov 11, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% | Oct 22, 2026 |
| MVIR.ST | Medivir AB (publ) | 2.08 SEK | +14.29% | +351.19% | +4.73% | Nov 5, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.70 SEK | −12.97% | −47.45% | −60.78% | Nov 3, 2026 |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% | Nov 11, 2026 |
| SEZI.ST | Senzime AB (publ) | 3.78 SEK | +3.28% | −30.35% | −39.98% | Oct 29, 2026 |
| FLUO.ST | FluoGuide A/S | 33.40 SEK | +6.71% | −9.49% | −18.34% | Nov 26, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% | Oct 22, 2026 |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% | Nov 25, 2026 |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% | Oct 22, 2026 |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% | Nov 3, 2026 |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% | Nov 12, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| VIVE.ST | Vivesto AB | 8.90 SEK | +3.01% | −21.10% | −57.13% | Nov 12, 2026 |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.38 SEK | −0.36% | −91.79% | −93.99% | Nov 12, 2026 |
| IMP-A-SDB.ST | Implantica AG | 58.00 SEK | −1.69% | +12.19% | −20.44% | Nov 19, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.